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Introduction
Endometriosis is defined as the presence of endometriotic glands 
outside the uterus. In addition to peritoneal endometriosis and 
ovarian endometriosis, a third form has been defined: deep infil-
trating endometriosis (DIE), in which the endometriotic glands in-
vade  > 5 mm into the underlying tissue [1]. It can cause pelvic pain, 
dysmenorrhea, dyspareunia, dyschezia and urinary tract symptoms 
depending on the anatomical location [2]. An accurate diagnosis 
of DIE is mandatory to help the patient make a choice regarding 
the different treatment options: medical, surgical and/or to plan a 
fertility treatment [3].
MRI and ultrasound both have their advantages and disadvan-
tages in the diagnosis of endometriosis. Transvaginal ultrasound 
(TVUS) is better at detecting rectal nodules (accuracy TVUS 95.8 % 
vs. MRI 94.9 %) [4–6], whereas MRI is a better method for evaluat-
ing the extent of pelvic endometriosis with an accuracy of 90.8 % 
[4]. Both TVUS and MRI are operator-dependent and therefore de-
pend on the experience of the gynecologist or the radiologist for 
accurate staging of DIE. Combining different ultrasonic features 
with standard TVUS examination, such as the uterine sliding sign, 
hard and soft markers (for instance hydrosalpinx or loculated fluid), 
the mobility of the pelvic organs and tenderness-guided ultrasound 
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ABStR Act
Purpose It was the aim of our study to evaluate this procedure 
using pelvic anatomical landmarks in order to assess the accu-
racy of fusion imaging and to critically evaluate the applicabil-
ity in daily practice.
Methods In a prospective, single center study, 10 patients with 
clinical signs of deep infiltrating endometriosis (DIE) were 
selected. We measured the distance between the landmark 
organ and the target shown by the software system (measure-
ment 1). Measurement 2 depicts the distance between the 
landmark and the nearest calibration point. The calibration 
inaccuracy was measured as a third type of measurement 
(measurement 3).
Results Measurement 1: the average distance between the 
organ landmark to the target was 13.6 mm (range: 0–96 mm). 
Measurement 2: in 31 of the 40 attempts (77.5 %), we could 
measure the distance from the landmark organ to the nearest 
calibration point. The average distance was 34.4 mm (range: 
0–69 mm).
Measurement 3: A perfect match was seen in 6 of 20 attempts 
(30.0 %). There was a deviation in 14 of the 20 attempts 
(70.0 %). The mean distance was 11.1 mm (range: 6–23 mm).
Conclusion Although very promising, MRI-ultrasound fusion 
imaging (MUFI) currently cannot be readily implemented into 
daily practice as a routine evaluation of DIE.
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results in more dynamic transvaginal ultrasound and may help to 
identify DIE easier [7–11].
Fusion imaging is a new technology, merging cross-sectional 
imaging data with ultrasound images in a real-time setting. MRI-ul-
trasound fusion imaging (MUFI) has proven useful in locating small 
prostate tumors: more accurate biopsies can be taken using MUFI 
[12–16].
Millischer et al. [17] have applied fusion imaging in the field of 
gynecology. Their aim was to assess the main anatomical sites of 
deep infiltrating endometriosis in patients with suspected active 
endometriosis. They showed that fusion imaging of uterosacral lig-
aments, rectum, posterior vaginal fornix, ureters and bladder is 
feasible and concluded that this technique had the potential to im-
prove the performance of ultrasound and MRI examination. How-
ever, their conclusions were based on superimposition of both MRI 
and ultrasound images by visual inspection [17].
It was the aim of our study to evaluate this procedure in patients 
with possible abnormal anatomy by using pelvic anatomical land-
marks in order to assess the accuracy of fusion imaging and criti-
cally evaluate the applicability in daily practice.
Methods
A prospective single-center study was conducted over a 6-month 
period. Patients with symptoms associated with endometriosis and 
with a strong suspicion of DIE were referred to our specialized clin-
ic for endometriosis and were invited to participate in our study. 
We excluded patients with an MRI scan longer than 90 days prior 
to MUFI. The diagnosis of DIE was made as descried by Bazot et al. 
[4]: in summary: hyperintense foci on the fat-suppression T1 im-
ages with corresponding hemorrhagic foci on T2 images, areas 
of fibrosis in pelvic region, distortion of normal anatomy without 
any other explanation or discontinuation of normal fatty tissue 
between organs. The diagnostic criteria of DIE on ultrasound were 
in accordance with the criteria described by the IDEA consensus 
UOG [11]. Patients with an MRI scan with movement artifacts were 
excluded.
For this study, MUFI was considered to be the reference image. 
All MRI scans were evaluated by a single radiologist (O.H., more 
than 10 years of abdominal cross-sectional imaging experience). 
Fusion MRI-ultrasound was performed by O.H. (radiologist) and J.B. 
(gynecologist), both of whom are endometriosis imaging experts. 
The MRI exams were performed on a 1.5-T superconducting mag-
net (Magnetom Avantofit TM; Siemens, Erlangen, Germany) using 
an 18-channel RF body coil.
The MRI protocol consisted of multiplanar TSE T2-weighted im-
ages: 512 matrix, axial, sagittal and coronal with a voxel size: 
0.8 × 0.8 × 4.0 and axial and sagittal T1 fat-saturated breath-hold 
sequences: 320 matrix voxel size: 1.3 × 1.3 × 6.0 mm. These proto-
cols did not include an isovolumetric sequence. Prior to examina-
tion, patients were administrated 20 mg butylscopolamine bro-
mide for bowel movement inhibition. No enema was administered 
and patients did not fast. No contrast was used. The bladder was 
not emptied before MRI or MUFI. With an empty bladder, nodules 
in the bladder are more difficult to visualize. The filling of the blad-
der is comparable in both techniques.
The MRI-ultrasound fusion examination was performed with a 
Toshiba APLIO 500 TM system, using a vaginal convex array trans-
ducer (5–9 Hz) and the smart fusion TM software and hardware 
features. The position sensor unit was attached to the vaginal probe 
and a transmitter was placed near the patient during the exam. Be-
fore scanning, the axial and sagittal images were uploaded to the 
smart fusion TM software. To visualize both the MRI images and 
the transvaginal scanning images simultaneously, we used 2-point 
calibration on the uterus: 1 point on the fundus of the uterus, 1 
point on the uterine cervix. A similar technique was used as de-
scribed by Millischer et al. except they used 1-point calibration [17].
In all patients, we attempted to assess the following landmarks: 
Right and left ovaries (if present), posterior vaginal fornix, rectum, 
uterus and the urethra orifice in the bladder. We chose these land-
marks because these anatomical sites are most affected by DIE, ex-
cept for the urethra orifice. The latter we chose to have one site that 
is normally not affected by endometriosis as a ‘control’ landmark.
First, a mark was put on the anatomical site to be evaluated on 
the MRI scan (landmark organ). Next, the corresponding mark 
on the ultrasound image was identified (target organ). Finally, a 
superimposition of the two images was constructed and the 
distance between the target organ and the mark was measured 
(measurement 1). Depending on the target organ, the ultrasound 
probe was positioned either in the anterior (bladder, urethra) or 
posterior fornix (rectum, ovary, uterus, posterior fornix). Multiple 
superimpositions per patient were constructed.
After measurement 1, we proceeded to measurement 2. To eval-
uate the distance between the target organ and the calibration 
point, we visualized both the mark on the target organ and the 
nearest calibration point in one image. Next, the distance between 
the target organ and the nearest calibration point was measured 
(measurement 2).
Finally, during the procedure, we re-evaluated the calibration 
with 5-min intervals: an overlay of the two images was constructed 
and the distance between the calibration point on MRI and ultra-
sound was measured.
Statistical	analysis
To evaluate the correlation between the accuracy of measurement 
1 (distance between organ landmark and MRI fusion target) and 
measurement 2 (distance between organ landmark and calibration 
point), Spearman’s correlation was used.
Ethics
The regional ethical committee approved our study. Written con-
sent was obtained in all patients.
Results
We selected 20 patients with clinical suspicion of DIE who had 
undergone a pelvic MRI scan. 14 patients underwent an MRI scan 
without any movement artifacts. We invited them to participate in 
our study. Of those patients, 10 agreed to volunteer to come in for 
an extra visit and participate in our study. In 7 out of 10 patients, 
DIE was confirmed by histology obtained by laparoscopy. 2 patients 
refused laparoscopy and in 1 patient the diagnosis of DIE was 
rejected by MUFI.
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The mean age was 28.3 years (range: 20–36 year). The mean 
time interval between MRI and fusion imaging was 42.9 days 
(range: 17–79 days). All measurements including calibration and 
recalibration were performed within 18.75 min (mean: 7:42 min, 
range: 4.20-18.75 min) (▶table 1).
Measurement	1
In 37 of the 40 assessments (92.5 %) we could measure the distance 
from the landmark organ to the fusion target point. The average 
distance was 13.6 mm (range: 0–96 mm). In 3 assessments, it was 
not possible to measure the distance, because we could not visu-
alize the landmark organ and the target in one image.
Measurement	2
31 of the 40 assessments were complete (77.5 %), and 9 assess-
ments were incomplete. The measurement of the distance be-
tween the landmark organ and the nearest calibration point was 
not feasible, since it was not possible to visualize both points in one 
ultrasound image. The average distance was 34.4 mm (range: 
0–69 mm).
▶table 1 Demographics.
Age 28.3 years (range: 20-36 years)
BMI 25.6 kg/m2 (range: 27-35.5 kg/m2)
Dysmenorrhea 9/10 (90 %)
Dyspareunia 6/10 (60 %)
Dysuria 3/12 (30 %)
Dyschezia 5/10 (50 %)
Time interval between MRI and  
MUFI
42.9 days (range: 17-79 days)
Time MUFI procedure 7:42 min (range: 4.20-18.75 min)
a
b
▶Fig. 1 a Measurement 1: The circle was placed on the landmark organ on MRI (ovary, ellipse, left) and reappeared on the TVUS on the target 
organ (ovary, ellipse, right). This was a perfect match. b The small circle with X was put on the landmark organ (uretric orifice, asterix, left) and reap-
peared on the TVUS on another part of the bladder. The deviation was measured. The circle without X is the calibration point.
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Measurement	3
Every 5 min during the examinations we evaluated the calibration. 
We tried to match our 2-point calibration between MRI and ultra-
sound. In 6 of 20 attempts (30.0 %), the superimposition was per-
fect. There was a deviation in 14 of the 20 attempts (70.0 %). In the 
latter case, the mean distance was 11.1 mm (range: 6–23 mm).
We correlated measurement 1 (the distance between the land-
mark organ to the MRI fusion target shown by the software) to 
measurement 2 (the distance between the organ landmark and 
calibration point) using Spearman’s correlation. Spearman’s rho 
was 0.149 (p = 0.433).
Discussion
Our findings, based on more quantitative measurements, are com-
parable with the results of Millischer et al. We also found good 
visualization of predetermined targets[17], but the image between 
MRI and MUFI was not always in a perfect superimposition. 
We found a mean difference of 13.6 mm between MRI and MUFI 
(▶Fig. 1b). The difference can be explained by multiple factors: 
Firstly, pelvic contents are dynamic most of the time. So, with 
a slightly different position of the uterus, the ovaries may have a 
different position too. Secondly, the TVUS probe moves organs out 
of their position on the MRI scan. And thirdly, patient movements 
may also influence measurements. To minimize the latter move-
ment factors, we checked the calibration every 5 min. In 6 attempts 
we found a perfect match (▶Fig. 3a), and in 14 attempts we did 
not (▶Fig. 3b). In the protocol described by Millischer et al., a cali-
bration is only performed at the beginning of the procedure[17]. 
In our experience, recalibration during the procedure is necessary, 
especially after patient movement or when the targets are further 
away. However, we could not establish significance, so more fac-
tors influencing the measurements are likely to be involved. To as-
sess accuracy, a more detailed protocol utilizing bladder filling and 
calibration close to the target organ should be used. Also, an extra 
(possibly 3D) MRI sequence may contribute to the accuracy of MUFI 
(▶Fig. 2).
Besides the need to invest in the hardware and software for this 
technique and in training for gynecologists using MUFI, some crit-
ical remarks need to be addressed before we implement this tech-
nique in our daily practice. Firstly and most importantly, the MRI 
scan needs to be free of movement artifacts and with good reso-
lution. Secondly, for logistical reasons, the MUFI scan cannot be 
performed on the same day as the MRI scan, so an extra visit for the 
patient to the clinic needs to be planned. Finally, the cost-effective-
ness of adding MUFI for the diagnosis of DIE is not well established 
yet. However, this was not within the scope of our study.
The question as to whether the MUFI technique makes sense for 
biopsies in (deep) endometriosis can be raised. For prostate can-
cer, MUFI has been shown to be very useful in taking biopsies. In 
patients with an elevated PSA, prostate cancer can be difficult to 
visualize on ultrasound, while endorectal MRI is superior. Since tak-
ing a biopsy during MRI scanning is not possible, MUFI is an excel-
lent technique to take more accurate biopsies than using ultra-
sound alone [12, 14–16]. Similar results have been obtained in the 
diagnosis of hepatocellular carcinoma [18]. However, routine 
biopsies are not common practice in patients with DIE. Therefore, 
this advantage of MUFI is questionable for this reason. However, 
when a discrepancy between TVUS and MRI is found, MUFI may 
have a place in the diagnostic pathway for DIE.
As mentioned earlier, the advantage of using more dynamic 
transvaginal ultrasound is the ability to evaluate the ‘sliding sign’, 
mobility of the pelvic organs and site-specific pain [6–10]. This will 
provide the gynecologist additional information which contributes 
to the assessment of the correct stage of disease. Moreover, an 
accurate diagnosis of DIE will help the patient make an informed 
decision regarding the therapeutic options [3]. Since TVUS for the 
assessment of DIE has a learning curve [19], not every hospital 
has a well-trained ultrasonographer for detecting DIE. One of the 
biggest challenges for gynecologists is the lack of anatomic orien-
▶Fig. 2 Measurement 2: The distance between the landmark organ (ovary, ellipse, left) and the nearest calibration point (uterus, small circle) 
was measured.
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a
b
▶Fig. 3 a Measurement 3: Calibration check with 2-point calibration. Circle with X (ovula Nabothi, cervix) big circle: posterior fornix. The right part 
of the picture (i. e., the TVUS image) has been zoomed in to focus on the landmarks. b Calibration check with 2 calibration points: circle with small 
circle inside: internal cervical ostium, circle with big circle inside: external cervical ostium, solitary circle: landmark organ (bowel)
tation when interpreting MR imaging for endometriosis. The field-
of-view is turned by 90 degrees compared to TVUS imaging. In clin-
ics where a dedicated sonographer is not present, MUFI may 
contribute to the diagnosis and staging of DIE by linking the imag-
es of MRI and TVUS. However, in our opinion, there is no place for 
the routine use of MUFI in the diagnosis of endometriosis.
To conclude, fusion imaging for DIE is a feasible, reproducible 
new technique. These initial results show promising accuracy and 
combine the positive effects of both MRI and TVUS imaging. How-
ever, before implementing this technique in daily practice, im-
provement in the software and more precise clinical conditions 
need to be met. Recently, Yavariabdi et al. [20] reported on the 
mapping and characterizing endometrial implants by registering 
2D TVUS to 3D pelvic MRI, using advanced computerized model-
ling approaches. Although very promising, at present MUFI cannot 
be readily implemented into daily practice as a routine evaluation 
of DIE. The cost-effectiveness of adding MUFI for the diagnosis of 
DIE can be questioned. However, this was not within the scope of 
this article.
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